Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation

Abstract Aims Concurrent mitral regurgitation (MR) influences treatment considerations in patients with severe aortic stenosis (sAS). Limited information exists regarding haemodynamic effects of sAS on MR severity and outcome of these patients. We assessed the impact of aortic valve replacement (AVR...

Full description

Bibliographic Details
Main Authors: Nahoko Kato, Jeremy J. Thaden, William R. Miranda, Christopher G. Scott, Maurice E. Sarano, Kevin L. Greason, Patricia A. Pellikka
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13649
_version_ 1818203841075609600
author Nahoko Kato
Jeremy J. Thaden
William R. Miranda
Christopher G. Scott
Maurice E. Sarano
Kevin L. Greason
Patricia A. Pellikka
author_facet Nahoko Kato
Jeremy J. Thaden
William R. Miranda
Christopher G. Scott
Maurice E. Sarano
Kevin L. Greason
Patricia A. Pellikka
author_sort Nahoko Kato
collection DOAJ
description Abstract Aims Concurrent mitral regurgitation (MR) influences treatment considerations in patients with severe aortic stenosis (sAS). Limited information exists regarding haemodynamic effects of sAS on MR severity and outcome of these patients. We assessed the impact of aortic valve replacement (AVR) on MR according to mechanism in patients with sAS and MR. Methods and results In patients with sAS who received surgical or transcatheter AVR from 2008 to 2017, those with effective mitral regurgitant orifice area (ERO) ≥ 10 mm2 prior to AVR were evaluated. The change in MR after AVR was considered significant when there was at least one grade difference. We compared the all‐cause mortality of patients with and without improvement in MR. Of 234 patients with sAS and MR (age 80 ± 9 years, 52% male, ERO 19 ± 7 mm2), organic and functional MR were present in 166 (71%) and 68 (29%), respectively. MR improved in 136 (58%); improvement occurred with similar frequency in organic versus functional MR (59% and 57%, P = 0.88). Associated determinants were absence of atrial fibrillation in organic MR [odds ratio (OR) 2.09, 95% confidence interval (CI) 1.00–4.37; P = 0.049] and indexed aortic valve area (iAVA) ≤ 0.40 cm2 in functional MR (OR 3.28, 95% CI 1.13–9.47; P = 0.028). In the overall cohort, mitral annulus diameter < 3 cm (OR 1.74, 95% CI 1.02–2.97; P = 0.041) and QRS duration < 115 ms (OR 1.73, 95% CI 1.00–2.98; P = 0.049) were independently associated with improvement in MR. During median follow‐up of 3.5 years, lack of improvement in MR was not associated with higher mortality in the overall cohort of patients with ERO ≥ 20 mm2 [adjusted hazard ratio (HR) 1.71, 95% CI 0.90–3.27; P = 0.10, adjusted for age, New York Heart Association III or IV, diabetes, and creatinine ≥ 2.0 mg/dL]. Lack of improvement in organic MR was associated with higher mortality (adjusted HR 3.36, 95% CI 1.40–8.05; P < 0.01). In patients with functional MR, change in MR was not associated with mortality (HR 1.24, 95% CI 0.44–3.47; P = 0.68). Conclusions In nearly 60% of patients with sAS and MR, MR improved after AVR, even in the majority of patients with organic MR. Absence of atrial fibrillation in organic MR, iAVA ≤ 0.40 cm2 in functional MR, and mitral annulus diameter < 3 cm and QRS duration < 115 ms in the overall population were associated with MR improvement. Post‐operative improvement in organic MR was associated with better survival.
first_indexed 2024-12-12T03:31:45Z
format Article
id doaj.art-c13c942fbb5f414c9c0eec8c5fede172
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-12T03:31:45Z
publishDate 2021-12-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-c13c942fbb5f414c9c0eec8c5fede1722022-12-22T00:39:54ZengWileyESC Heart Failure2055-58222021-12-01865482549210.1002/ehf2.13649Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitationNahoko Kato0Jeremy J. Thaden1William R. Miranda2Christopher G. Scott3Maurice E. Sarano4Kevin L. Greason5Patricia A. Pellikka6Department of Cardiovascular Medicine Mayo Clinic 200 First Street Southwest Rochester MN USADepartment of Cardiovascular Medicine Mayo Clinic 200 First Street Southwest Rochester MN USADepartment of Cardiovascular Medicine Mayo Clinic 200 First Street Southwest Rochester MN USADepartment of Health Sciences Research Mayo Clinic Rochester MN USADepartment of Cardiovascular Medicine Mayo Clinic 200 First Street Southwest Rochester MN USADepartment of Cardiovascular Surgery Mayo Clinic Rochester MN USADepartment of Cardiovascular Medicine Mayo Clinic 200 First Street Southwest Rochester MN USAAbstract Aims Concurrent mitral regurgitation (MR) influences treatment considerations in patients with severe aortic stenosis (sAS). Limited information exists regarding haemodynamic effects of sAS on MR severity and outcome of these patients. We assessed the impact of aortic valve replacement (AVR) on MR according to mechanism in patients with sAS and MR. Methods and results In patients with sAS who received surgical or transcatheter AVR from 2008 to 2017, those with effective mitral regurgitant orifice area (ERO) ≥ 10 mm2 prior to AVR were evaluated. The change in MR after AVR was considered significant when there was at least one grade difference. We compared the all‐cause mortality of patients with and without improvement in MR. Of 234 patients with sAS and MR (age 80 ± 9 years, 52% male, ERO 19 ± 7 mm2), organic and functional MR were present in 166 (71%) and 68 (29%), respectively. MR improved in 136 (58%); improvement occurred with similar frequency in organic versus functional MR (59% and 57%, P = 0.88). Associated determinants were absence of atrial fibrillation in organic MR [odds ratio (OR) 2.09, 95% confidence interval (CI) 1.00–4.37; P = 0.049] and indexed aortic valve area (iAVA) ≤ 0.40 cm2 in functional MR (OR 3.28, 95% CI 1.13–9.47; P = 0.028). In the overall cohort, mitral annulus diameter < 3 cm (OR 1.74, 95% CI 1.02–2.97; P = 0.041) and QRS duration < 115 ms (OR 1.73, 95% CI 1.00–2.98; P = 0.049) were independently associated with improvement in MR. During median follow‐up of 3.5 years, lack of improvement in MR was not associated with higher mortality in the overall cohort of patients with ERO ≥ 20 mm2 [adjusted hazard ratio (HR) 1.71, 95% CI 0.90–3.27; P = 0.10, adjusted for age, New York Heart Association III or IV, diabetes, and creatinine ≥ 2.0 mg/dL]. Lack of improvement in organic MR was associated with higher mortality (adjusted HR 3.36, 95% CI 1.40–8.05; P < 0.01). In patients with functional MR, change in MR was not associated with mortality (HR 1.24, 95% CI 0.44–3.47; P = 0.68). Conclusions In nearly 60% of patients with sAS and MR, MR improved after AVR, even in the majority of patients with organic MR. Absence of atrial fibrillation in organic MR, iAVA ≤ 0.40 cm2 in functional MR, and mitral annulus diameter < 3 cm and QRS duration < 115 ms in the overall population were associated with MR improvement. Post‐operative improvement in organic MR was associated with better survival.https://doi.org/10.1002/ehf2.13649Mitral regurgitationAortic stenosisValve diseaseEchocardiography
spellingShingle Nahoko Kato
Jeremy J. Thaden
William R. Miranda
Christopher G. Scott
Maurice E. Sarano
Kevin L. Greason
Patricia A. Pellikka
Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
ESC Heart Failure
Mitral regurgitation
Aortic stenosis
Valve disease
Echocardiography
title Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
title_full Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
title_fullStr Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
title_full_unstemmed Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
title_short Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
title_sort impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation
topic Mitral regurgitation
Aortic stenosis
Valve disease
Echocardiography
url https://doi.org/10.1002/ehf2.13649
work_keys_str_mv AT nahokokato impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT jeremyjthaden impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT williamrmiranda impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT christophergscott impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT mauriceesarano impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT kevinlgreason impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation
AT patriciaapellikka impactofaorticvalvereplacementforsevereaorticstenosisonorganicandfunctionalmitralregurgitation